Newbridge Financial Services Group, Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 119 filers reported holding ORAMED PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,715
-27.1%
6570.0%0.00%0.0%
Q2 2023$2,352
+64.2%
6570.0%0.00%0.0%
Q1 2023$1,432
-81.9%
6570.0%0.00%
-80.0%
Q4 2022$7,904
+97.6%
6570.0%0.01%
+150.0%
Q3 2022$4,000
+33.3%
6570.0%0.00%0.0%
Q2 2022$3,000
-50.0%
6570.0%0.00%
-33.3%
Q1 2022$6,000
-33.3%
6570.0%0.00%
-25.0%
Q4 2021$9,0006570.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders